Full Text
Orphan Drug Reimbursement In Europe- Do Less Stringent Regulatory Requirements Translate Into Less Favourable Reimbursement?

Abstract

Authors

E Anastasaki R Macaulay

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×